MinMed: Do Older Adults do Better With Less Medication
Launched by UNIVERSITY OF ALBERTA · Mar 23, 2022
Trial Information
Current as of June 29, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
PURPOSE
To organize primary care providers, and their older patients with polypharmacy, in a way that permits them to collaboratively determine the lowest effective dose of all amenable medications. And, in so doing, to provide randomized controlled trial evidence as to whether minimizing medication doses improves health outcomes in this population.
HYPOTHESIS
1. Primary care providers can easily reduce medication doses in their own patients when organized appropriately to do so.
2. Determining and utilizing the minimum effective dose of all medications will prolong independence, reduce ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Attached to participating primary care providers
- • 2. Community dwelling (i.e. not living in a nursing home or supportive living facility)
- • 3. ≥80 years of age
- • 4. Using ≥6 long-term oral medications (defined as orally administered medications dispensed ≥2 times in the preceding 200 days)
- Exclusion Criteria:
- • None
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Scott Garrison, MD, PhD
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials